- Home
- EQ
EQ
Equillium Inc.
as 05-30-2025 4:00pm EST
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | N/A | IPO Year: | 2018 |
| Target Price: | $3.00 | AVG Volume (30 days): | 65.9K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.34 - $1.53 | Next Earning Date: | 05-14-2025 |
| Revenue: | $30,406,000 | Revenue Growth: | -19.76% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Equillium Inc. News
EQ Breaking Stock News: Dive into EQ Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists
Business Wire
a month ago
Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504
Business Wire
a month ago
Equillium Announces Feedback from the U.S. Food and Drug Administration
Simply Wall St.
2 months ago
Promising Penny Stocks To Consider In April 2025
Zacks
2 months ago
Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Simply Wall St.
2 months ago
Equillium Full Year 2024 Earnings: Beats Expectations
MT Newswires
2 months ago
Leerink Partners Downgrades Equillium to Market Perform From Outperform, Adjusts Price Target to $1 From $3
Clinical Trials Arena
2 months ago
Equillium pushes for breakthrough status despite missing primary endpoint
Compare EQ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EQ Equillium Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.